Molecular mechanisms linking wound inflammation and fibrosis: Knockdown of osteopontin leads to rapid repair and reduced scarring

Journal of Experimental Medicine

Volumn 205, Issue 1, 2008, Pages 43-51

  Mori, Ryoichi ^a   Shaw, Tanya J ^a   Martin, Paul ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IMATINIB; OSTEOPONTIN; ANTISENSE OLIGONUCLEOTIDE; BONE SIALOPROTEIN; SIALOGLYCOPROTEIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; DISEASE ASSOCIATION; FIBROSIS; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; WOUND; WOUND HEALING; ANIMAL; BIOLOGICAL MODEL; CELL STRAIN 3T3; CHEMISTRY; EXTRACELLULAR MATRIX; FIBROBLAST; GENETICS; LEUKOCYTE; MACROPHAGE; MAST CELL; METABOLISM; NEUTROPHIL; PATHOLOGY; PHYSIOLOGY; RAT; SCAR;

3T3 CELLS; ANIMALS; CICATRIX; EXTRACELLULAR MATRIX; FIBROBLASTS; FIBROSIS; INFLAMMATION; LEUKOCYTES; MACROPHAGES; MAST CELLS; MICE; MODELS, BIOLOGICAL; NEUTROPHILS; OLIGONUCLEOTIDES, ANTISENSE; OSTEOPONTIN; RATS; SIALOGLYCOPROTEINS; WOUND HEALING;

EID: 38749106966     PISSN: 00221007     EISSN: 00221007     Source Type: Journal    
DOI: 10.1084/jem.20071412     Document Type: Article

References (30)

1. Martin, P., and S.J. Leibovich. 2005. Inflammatory cells during wound repair: the good, the bad and the ugly. Trends Cell Biol. 15:599-607.
2. Chatziantoniou, C., and J.C. Dussaule. 2005. Insights into the mechanisms of renal fibrosis: is it possible to achieve regression? Am. J. Physiol. Renal Physiol. 289:F227-F234.
3. Keane, M.P., R.M. Strieter, and J.A. Belperio. 2005. Mechanisms and mediators of pulmonary fibrosis. Crit. Rev. Immunol. 25:429-463.
4. Duffield, J.S., S.J. Forbes, C.M. Constandinou, S. Clay, M. Partolina, S. Vuthoori, S. Wu, R. Lang, and J.P. Iredale. 2005. Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. J. Clin. Invest. 115:56-65.
5. Martin, P., D. D'Souza, J. Martin, R. Grose, L. Cooper, R. Maki, and S.R. McKercher. 2003. Wound healing in the PU.1 null mouse-tissue repair is not dependent on inflammatory cells. Curr. Biol. 13:1122-1128.
6. Cooper, L., C. Johnson, F. Burslem, and P. Martin. 2005. Wound healing and inflammation genes revealed by array analysis of 'macrophage-less' PU.1 null mice. Genome Biol. 6:R5.
7. Pardo, A., K. Gibson, J. Cisneros, T.J. Richards, Y. Yang, C. Becerril, S. Yousem, I. Herrera, V. Ruiz, M. Selman, and N. Kaminski. 2005. Up-regulation and profibrotic role of osteopontin in human idiopathic pulmonary fibrosis. PLoS Med. 2:e251.
8. Lee, S.H., G.S. Seo, Y.N. Park, T.M. Yoo, and D.H. Sohn. 2004. Effects and regulation of osteopontin in rat hepatic stellate cells. Biochem. Pharmacol. 68:2367-2378.
9. El-Tanani, M.K., F.C. Campbell, V. Kurisetty, D. Jin, M. McCann, and P.S. Rudland. 2006. The regulation and role of osteopontin in malignant transformation and cancer. Cytokine Growth Factor Rev. 17:463-474.
10. Shinohara, M.L., L. Lu, J. Bu, M.B. Werneck, K.S. Kobayashi, L.H. Glimcher, and H. Cantor. 2006. Osteopontin expression is essential for interferon-alpha production by plasmacytoid dendritic cells. Nat. Immunol. 7:498-506.
11. Denhardt, D.T., M. Noda, A.W. O'Regan, D. Pavlin, and J.S. Berman. 2001. Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival. J. Clin. Invest. 107:1055-1061.
12. Liaw, L., D.E. Birk, C.B. Ballas, J.S. Whitsitt, J.M. Davidson, and B.L. Hogan. 1998. Altered wound healing in mice lacking a functional osteopontin gene (spp1). J. Clin. Invest. 101:1468-1478.
13. Sharma, A., A.K. Singh, J. Warren, R.L. Thangapazham, and R.K. Maheshwari. 2006. Differential regulation of angiogenic genes in diabetic wound healing. J. Invest. Dermatol. 126:2323-2331.
14. Matsui, Y., N. Jia, H. Okamoto, S. Kon, H. Onozuka, M. Akino, L. Liu, J. Morimoto, S.R. Rittling, D. Denhardt, et al. 2004. Role of osteopontin in cardiac fibrosis and remodeling in angiotensin II-induced cardiac hypertrophy. Hypertension. 43:1195-1201.
15. Canty, E.G., and K.E. Kadler. 2005. Procollagen trafficking, processing and fibrillogenesis. J. Cell Sci. 118:1341-1353.
16. Butler, W.T. 1995. Structural and functional domains of osteopontin. Ann. N. Y. Acad. Sci. 760:6-11.
17. Velling, T., J. Risteli, K. Wennerberg, D.F. Mosher, and S. Johansson. 2002. Polymerization of type I and III collagens is dependent on fibronectin and enhanced by integrins alpha 11beta 1 and alpha 2beta 1. J. Biol. Chem. 277:37377-37381.
18. Giachelli, C.M., D. Lombardi, R.J. Johnson, C.E. Murry, and M. Almeida. 1998. Evidence for a role of osteopontin in macrophage infiltration in response to pathological stimuli in vivo. Am. J. Pathol. 152:353-358.
19. Egozi, E.I., A.M. Ferreira, A.L. Burns, R.L. Gamelli, and L.A. Dipietro. 2003. Mast cells modulate the inflammatory but not the proliferative response in healing wounds. Wound Repair Regen. 11:46-54.
20. Frank, S., M. Madlener, and S. Werner. 1996. Transforming growth factors beta1, beta2, and beta3 and their receptors are differentially regulated during normal and impaired wound healing. J. Biol. Chem. 271:10188-10193.
21. Leali, D., E. Moroni, F. Bussolino, and M. Presta. 2007. Osteopontin overexpression inhibits in vitro re-endothelialization via integrin engagement. J. Biol. Chem. 282:19676-19684.
22. Mori, R., T. Kondo, T. Ohshima, Y. Ishida, and N. Mukaida. 2002. Accelerated wound healing in tumor necrosis factor receptor p55-deficient mice with reduced leukocyte infiltration. FASEB J. 16:963-974.
23. Trautmann, A., A. Toksoy, E. Engelhardt, E.B. Brocker, and R. Gillitzer. 2000. Mast cell involvement in normal human skin wound healing: expression of monocyte chemoattractant protein-1 is correlated with recruitment of mast cells which synthesize interleukin-4 in vivo. J. Pathol. 190:100-106.
24. Rappolee, D.A., D. Mark, M.J. Banda, and Z. Werb. 1988. Wound macrophages express TGF-alpha and other growth factors in vivo: analysis by mRNA phenotyping. Science. 241:708-712.
25. Rajkumar, V.S., X. Shiwen, M. Bostrom, P. Leoni, J. Muddle, M. Ivarsson, B. Gerdin, C.P. Denton, G. Bou-Gharios, C.M. Black, and D.J. Abraham. 2006. Platelet-derived growth factor-beta receptor activation is essential for fibroblast and pericyte recruitment during cutaneous wound healing. Am. J. Pathol. 169:2254-2265.
26. Chan, R.K., P.H. Liu, G. Pietramaggiori, S.I. Ibrahim, H.B. Hechtman, and D.P. Orgill. 2006. Effect of recombinant platelet-derived growth factor (Regranex) on wound closure in genetically diabetic mice. J. Burn Care Res. 27:202-205.
27. Lynch, S.E., J.C. Nixon, R.B. Colvin, and H.N. Antoniades. 1987. Role of platelet-derived growth factor in wound healing: synergistic effects with other growth factors. Proc. Natl. Acad. Sci. USA. 84:7696-7700.
28. Distler, J.H., A. Jungel, L.C. Huber, U. Schulze-Horsel, J. Zwerina, R.E. Gay, B.A. Michel, T. Hauser, G. Schett, S. Gay, and O. Distler. 2007. Imatinib mesylate reduces production of extracellular matrix and prevents development of experimental dermal fibrosis. Arthritis Rheum. 56:311-322.
29. Aono, Y., Y. Nishioka, M. Inayama, M. Ugai, J. Kishi, H. Uehara, K. Izumi, and S. Sone. 2005. Imatinib as a novel antifibrotic agent in bleomycin-induced pulmonary fibrosis in mice. Am. J. Respir. Crit. Care Med. 171:1279-1285.
30. Shah, M., D.M. Foreman, and M.W. Ferguson. 1995. Neutralisation of TGF-beta 1 and TGF-beta 2 or exogenous addition of TGF-beta 3 to cutaneous rat wounds reduces scarring. J. Cell Sci. 108:985-1002.